Jennifer A. Fox - 28 May 2026 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Reporting relationship: Director
Issuer ticker: PROK
Reported as of: 28 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 May 2026, 16:06:13 UTC
Prior SEC filing: 20 Jun 2025
Next SEC filing: 11 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Todd Girolamo, attorney in fact

Key filing fact

Jennifer A. Fox filed Form 4 for PROKIDNEY CORP. (PROK) on 29 May 2026.

Key facts

This page summarizes Jennifer A. Fox's Form 4 filing for PROKIDNEY CORP. (PROK).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 May 2026, 16:06.

Change

Previous filing in this sequence was filed on 20 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001841557 Primary reporting owner

Fox Jennifer A.

Relationship: Director
Address: C/O PROKIDNEY CORP, 2000 FRONTIS PLAZA BLVD, SUITE 250, WINSTON SALEM
Signature: /s/ Todd Girolamo, attorney in fact
Signature date: 29 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PROK transaction Derivative

Director stock option (right to buy)

Award

Transaction value
Shares: +135,000
Change %
Price: $0.000000^*
Shares after: 135,000
Date: 28 May 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 135,000
Exercise price: $1.81
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These options were granted under the Issuer's non-employee director compensation policy.

Footnote F2

The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting.